Effects of lifestyle modification on the progression of coronary atherosclerosis, autonomic function, and angina - The role of GNB3 C825T polymorphism

被引:19
|
作者
Michalsen, A
Knoblauch, NTM
Lehmann, N
Grossman, P
Kerkhoff, G
Wilhelm, FH
Moebus, S
Konstantinides, S
Binder, L
Heusch, G
Siffert, W
Budde, T
Dobos, GJ
机构
[1] Kliniken Essen Mitte, Innere Med Abt 5, D-45276 Essen, Germany
[2] Univ Klinikum Essen, Inst Med Informat Biometrie, Essen, Germany
[3] Univ Klinikum Essen, Inst Pathophysiol, Essen, Germany
[4] Univ Klinikum Essen, Inst Pharmakol, Essen, Germany
[5] Alfried Krupp Hosp, Abt Kardiol, Essen, Germany
[6] Univ Basel, Inst Psychol, CH-4003 Basel, Switzerland
[7] Univ Klinikum Gottingen, Abt Kardiol, Gottingen, Germany
关键词
D O I
10.1016/j.ahj.2005.06.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Given the multimodal medical and interventional treatment options in coronary artery disease, the additional value of intensified lifestyle modification is unclear. We have therefore examined the effects of lifestyle modification on top of current treatment and also associated with the GNB3 C825T polymorphism, which has established association to sympathetic activation and the precipitation of angina. Methods: One hundred one patients with established coronary artery disease were randomized to a 1-year lifestyle modification group (lifestyle group [LG]) or an advice group. Risk factors, coronary calcification (electron beam tomography), heart rate variability, baroreflex sensitivity, anginal symptoms, and quality of life (QOL) were assessed on entry and after 1 year. Results: Patients in LG had excellent program adherence, but lifestyle modification had no impact on metabolic risk factors and coronary calcification. Changes in heart rate, heart rate variability, and blood pressure were only slightly favoring LG. Baroreflex sensitivity increased by 2 (0.79-3.13) ms/mm Hg in the LG but decreased by -0.10 (-1.11 to 0.92) in the advice group (P = .013). Lifestyle modification led to improved physical QOL, reductions of anginal attacks (-54% vs 11%, P = .01), and dose reductions in 30% of anti-ischemic medications (P = .004). *825T allele carriers had a more pronounced reduction of heart rate and improvement of angina and QOL. The beneficial effect on reduction of medication was seen in *825T allele carriers only. Conclusions: In the presence of modern treatments, comprehensive lifestyle modification provides no additional benefits on progression of atherosclerosis but improves autonomic function, angina, and QOL with concomitant reduced need of medication. These responses are more pronounced in GN83*825T allele carriers.
引用
收藏
页码:870 / 877
页数:8
相关论文
共 50 条
  • [31] Effects of C825T polymorphism of the GNB3 gene on availabilities of dopamine transporters in healthy volunteers - a SPECT study 1
    Chan, Y. H.
    Yang, Y. K.
    Gean, P. W.
    Chen, P. S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 174 - 174
  • [32] The indices of arterial structure and function in relation to G protein beta 3 subunit gene (GNB3) polymorphism (C825T)
    Olszanecka, A
    Stolarz, K
    Lubaszewski, W
    Kiec-Wilk, B
    Wizner, B
    Grodzicki, T
    Dembinska-Kiec, A
    Kawecka-Jaszcz, K
    JOURNAL OF HYPERTENSION, 2004, 22 : S344 - S344
  • [33] Clinically silent adrenal adenomas - their relation to the metabolic syndrome and to GNB3 C825T gene polymorphism
    Lazurova, Ivica
    Spisakova, Daniela
    Wagnerova, Hedviga
    Habalova, Viera
    Dravecka, Ingrid
    Darina, Petrasova
    Drahovska, Ivica
    Pundova, Lydia
    WIENER KLINISCHE WOCHENSCHRIFT, 2011, 123 (19-20) : 618 - 622
  • [34] Genotype of the GNB3 C825T polymorphism. A risk factor for the development and course of prostate cancer?
    Eisenhardt, A.
    Scherag, A.
    Kempin, M.
    Joeckel, K. H.
    Ruebben, H.
    UROLOGE, 2011, 50 (09): : 1137 - 1142
  • [35] The C825T GNB3 Polymorphism, Independent of Blood Pressure, Predicts Cerebrovascular Risk at a Population Level
    Casiglia, Edoardo
    Tikhonoff, Valerie
    Boschetti, Giovanni
    Bascelli, Anna
    Saugo, Mario
    Guglielmi, Giuseppe
    Caffi, Sandro
    Rigoni, Giulio
    Giordano, Nunzia
    Grasselli, Carla
    Martini, Bortolo
    Mazza, Alberto
    De Lazzari, Fabia
    Palatini, Paolo
    AMERICAN JOURNAL OF HYPERTENSION, 2012, 25 (04) : 451 - 457
  • [36] GNB3 C825T Polymorphism and Elite Athletic Status: A Replication Study with Two Ethnic Groups
    Ruiz, J. R.
    Eynon, N.
    Meckel, Y.
    Fiuza-Luces, C.
    Santiago, C.
    Gomez-Gallego, F.
    Oliveira, J.
    Lucia, A.
    INTERNATIONAL JOURNAL OF SPORTS MEDICINE, 2011, 32 (02) : 151 - 153
  • [37] Myocardial Recovery in Peripartum Cardiomyopathy: Effect of the GNB3 C825T Polymorphism in the Multicenter IPAC study
    Sheppard, Richard
    Damp, Julie
    Keeley, Angela
    Ramani, Gautam
    Elkayam, Uri
    Hsich, Eileen
    Zucker, Mark
    Alexis, Jeffrey
    Hanley-Yanez, Karen
    Pisarcik, Jessica
    Halder, Indrani
    McNamara, Dennis M.
    CIRCULATION, 2015, 132
  • [38] The G-protein beta3 subunit (GNB3) C825T polymorphism and the risk for stroke
    Rosskopf, D
    Schürks, M
    Taake, A
    Siffert, W
    HYPERTENSION, 2001, 38 (04) : 978 - 978
  • [39] Sildenafil response is influenced by the G protein β3 subunit GNB3 C825T polymorphism:: A pilot study
    Sperling, H
    Eisenhardt, A
    Virchow, S
    Hauck, E
    Lenk, S
    Porst, H
    Stief, C
    Wetterauer, U
    Rübben, H
    Müller, N
    Siffert, W
    JOURNAL OF UROLOGY, 2003, 169 (03): : 1048 - 1051
  • [40] Evidence for a reduced availability of prostaglandins to counterbalance noradrenergic stimulation in veins of carriers of the GNB3 C825T polymorphism
    Rushentsova, U.
    Siffert, W.
    Philipp, T.
    Mitchell, A.
    JOURNAL OF HYPERTENSION, 2007, 25 : S384 - S384